精选49MarketWatch（RSS）股市多源精选 ×2
诺和诺德股价再跌，Wegovy口服药数据不及预期
Novo Nordisk stock is sliding again — and the Wegovy pill’s surprise miss is partly to blame
The Danish drugmaker also revealed an improved outlook for the year.
更进一步：量化金融体系
看懂新闻只是起点——沿量化金融路径，把它变成能交付的工程能力